Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MS-20 for Cachexia in Pancreatic Cancer
NCT04600154Unknown
- Sponsor
- National Taiwan University Hospital
- Start
- Aug 2021
- Primary completion
- Jun 2023
- Modality
- Complex Communities
- Countries
- 1
01
Overview
Randomised, double-blind trial in cachexia, fatigue and anorexia nervosa (AN) comparing MS-20 Arm with Placebo Arm (2 arms). Primary endpoint: Change in cachexia staging score at 12 weeks. Status: unknown.
02
Drugs
MicrSoy-20
03
Conditions
cachexiafatigueanorexia nervosa (AN)
Beyond the preview
Go deeper on NCT04600154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04600154.